Key facts
- This page summarizes Karen Drexler's Form 4 filing for Outset Medical, Inc. (OM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2026, 18:08.
Karen Drexler - 04 Jun 2026 Form 4 Insider Report for Outset Medical, Inc. (OM)
- Reporting relationship
- Director
- Issuer ticker
- OM
- Reported as of
- 04 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2026, 18:08:38 UTC
- Prior SEC filing
- 08 May 2026
- Source filing
- View source filing
- Reporting owner signature
- By: John L Brottem For: Karen Drexler
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Karen Drexler filed Form 4 for Outset Medical, Inc. (OM) on 05 Jun 2026.
Change
- Previous filing in this sequence was filed on 08 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001504699
Primary reporting owner
Drexler Karen
- Relationship
- Director
- Address
- 3052 ORCHARD DRIVE, SAN JOSE
- Signature
- By: John L Brottem For: Karen Drexler
- Signature date
- 05 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OM
transaction
Common Stock
Award
- Transaction value
- Shares
- +10,667
- Change %
- +100%
- Price
- $0.000000*
- Shares after
- 21,317
- Date
- 04 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
OM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,083
- Date
- 04 Jun 2026
- Ownership
- Drexler Family Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders